NAS
HRMY icon

Nykredit A/S’s Harmony Biosciences HRMY Stock Holding History

Nykredit A/S’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.7K Buy
+897
New +$28.3K ﹤0.01% 1592

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Nykredit A/S's HRMY Position: Q2 2026 in Review

Nykredit A/S opened a new position in Harmony Biosciences (HRMY) in Q2 2026: 897 shares worth $32.7K. The stake represents ﹤0.01% of the portfolio and ranks #1592 among its holdings.

234 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Nykredit A/S held 897 shares of Harmony Biosciences worth $32.7K as of Q2 2026.
  • Harmony Biosciences was a new Nykredit A/S position in Q2 2026.
  • Harmony Biosciences made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #1592 holding.
  • 234 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.